Orthofix Medical has launched a new O-GENESIS Graft Delivery System together with AlloQuent Structural Allograft Q-Pack, a ready-to-use form of cervical and lumbar spacers for allograft procedures.
The O-GENESIS Graft Delivery System is designed to provide allograft, autograft or synthetic bone graft to orthopaedic surgical sites.
It offers two streamlined loading options to accommodate a range of other bone graft materials, including fiberFUSE Demineralised Bone Matrix, the company noted.
Furthermore, the system is compatible with the company’s Trinity ELITE Allograft that features viable cells, processed specifically for the company by MTF Biologics.
Orthofix Spine global president Kevin Kenny said: “Orthofix is committed to continuous technology innovation and expanding solutions to improve operating room efficiencies.
“The unique design of the O-GENESIS Graft Delivery System enables one-handed delivery of bone graft material in a precise and controlled manner to aid surgeons with the targeted placement of biologics during orthopaedic surgeries.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
“Additionally, we are pleased to offer the new AlloQuent Structural Allograft in Q-Pack that allows for immediate use with no downtime for rehydrating. Both of these demonstrate our commitment to providing surgeons with easy-to-use solutions to meet the needs of their patients.”
The AlloQuent Structural Allografts are precision-machined cervical and lumbar spacers that are hydrated and ready-to-use.
The company has partnered with MTF Biologics to launch AlloQuent in the new Q-Pack Technology.
In July, Orthofix Medical received the Food and Drug Administration (FDA) 510(k) clearance and European CE Mark approval for its JuniOrtho Plating System designed for paediatric patients.